Literature DB >> 3420260

Avascular necrosis versus other diseases of the hip: sensitivity of MR imaging.

M F Glickstein1, D L Burk, M L Schiebler, E K Cohen, M K Dalinka, M E Steinberg, H Y Kressel.   

Abstract

Magnetic resonance (MR) imaging of the hip has been useful in the examination of patients for the presence of avascular necrosis (AVN). In the detection of AVN, MR imaging is more sensitive than computed tomography or nuclear scintigraphy. This study assessed the usefulness of MR imaging in the differentiation of AVN from other hip diseases. Twenty-two cases of non-AVN hip disease were matched with 23 biopsy-proved cases of AVN and ten normal controls. MR images were rated in a blinded manner by five experienced radiologists, and receiver operating characteristic (ROC) analysis was performed on the data. In the discrimination of AVN from other hip diseases or from normality, the A(z) value (the area under the ROC curve) was 98.6. With a specificity of 98%, MR imaging was 97% sensitive in the differentiation of AVN from normality, 85% sensitive in the differentiation of AVN from non-AVN disease, and 91% sensitive in the differentiation of AVN from both conditions. MR imaging may therefore help discriminate between AVN and other hip diseases.

Entities:  

Mesh:

Year:  1988        PMID: 3420260     DOI: 10.1148/radiology.169.1.3420260

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

Review 1.  [Magnetic resonance tomography and arthrography of the hip joint].

Authors:  G Schneider; A Massmann; P Fries; M Kusma; M Dienst
Journal:  Orthopade       Date:  2006-01       Impact factor: 1.087

Review 2.  Magnetic resonance imaging for acute hip pain in the emergency department.

Authors:  Sachin S Saboo; Yu-Ching Lin; Yu-Hsiang Juan; Ketan Patel; Michael Weaver; Aaron Sodickson; Bharti Khurana
Journal:  Emerg Radiol       Date:  2015-01-17

3.  Bone marrow oedema on MR imaging indicates ARCO stage 3 disease in patients with AVN of the femoral head.

Authors:  Reinhard Meier; Tobias M Kraus; Christoph Schaeffeler; Sebastian Torka; Anna Melissa Schlitter; Katja Specht; Bernhard Haller; Simone Waldt; Hans Rechl; Ernst J Rummeny; Klaus Woertler
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

4.  Avascular necrosis of the femoral head presenting as trochanteric bursitis.

Authors:  B F Mandell
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

Review 5.  Evolutionary course of the femoral head osteonecrosis: Histopathological - radiologic characteristics and clinical staging systems.

Authors:  Yiwei Chen; Yu Miao; Kexin Liu; Feng Xue; Bin Zhu; Changqing Zhang; Guangyi Li
Journal:  J Orthop Translat       Date:  2021-08-16       Impact factor: 4.889

6.  Bilateral hip arthritis in a case of renal osteodystrophy.

Authors:  Raju Vaishya; David Ndegwa Nyokabi; Abhishek Vaish
Journal:  BMJ Case Rep       Date:  2014-02-19

Review 7.  The role of imaging in diagnosis and management of femoral head avascular necrosis.

Authors:  Guglielmo Manenti; Simone Altobelli; Luca Pugliese; Umberto Tarantino
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

8.  Widespread osteonecrosis in children with leukemia revealed by whole-body MRI.

Authors:  Paivi Maria Miettunen; Lucie Lafay-Cousin; Gregory M T Guilcher; Alberto Nettel-Aguirre; Vijay Moorjani
Journal:  Clin Orthop Relat Res       Date:  2012-09-25       Impact factor: 4.176

9.  Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.

Authors:  Domenico Albano; Caterina Patti; Ludovico La Grutta; Emanuele Grassedonio; Antonino Mulè; Giuseppe Brancatelli; Roberto Lagalla; Massimo Midiri; Massimo Galia
Journal:  Eur Radiol       Date:  2016-08-13       Impact factor: 5.315

Review 10.  Nuclear medicine imaging in osteonecrosis of hip: Old and current concepts.

Authors:  Kanhaiyalal Agrawal; Sujit Kumar Tripathy; Ramesh Kumar Sen; S Santhosh; Anish Bhattacharya
Journal:  World J Orthop       Date:  2017-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.